Global Ischemia Reperfusion Injury Market Size, Share, and COVID-19 Impact Analysis, By Injury (Heart Injury, Kidney Injury, Intestine Injury, and Others), By End Users (Hospital, Clinics, Ambulatory Services, Nursing Home), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 - 2030

Industry: Healthcare
RELEASE DATE Mar 2023
REPORT ID SI1623
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis by Injury
      2. Market Attractiveness Analysis by End Users
      3. Market Attractiveness Analysis by Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Advancements in technology
    3. Restraints
      1. High cost of treatments
    4. Opportunities
      1. Technological Innovations
    5. Challenges
      1. Increasing Cost of drugs
  6. Global Ischemia Reperfusion Injury Market Analysis and Projection, By Injury
    1. Segment Overview
    2. Heart Injury
    3. Kidney Injury
    4. Intestine Injury
    5. Others
  7. Global Ischemia Reperfusion Injury Market Analysis and Projection, By End Users
    1. Hospital
    2. Clinics
    3. Ambulatory Services
    4. Nursing Home
  8. Global Ischemia Reperfusion Injury Market, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Ischemia Reperfusion Injury Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global Ischemia Reperfusion Injury Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Amyndas Pharmaceuticals LLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. ANGION
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Bolder Biotechnology
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. Opsona Therapeutics Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.  Pharming Group NV
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Prolong Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Prothix BV
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Stealth BioTherapeutics, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Zealand Pharma A/S
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Faraday Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  SBI Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.  Omeros Corporations
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.   Orexo AB
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Pledpharma AB
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Proteo
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table 

  1. Global Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  2. Global Heart Injury, Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  3. Global Kidney Injury, Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  4. Global Intestine Injury, Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  5. Global Others, Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  6. Global Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  7. Global Hospital, Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  8. Global Clinics, Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  9. Global Ambulatory Services, Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  10. Global Nursing Home, Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  11. Global Ischemia Reperfusion Injury Market, By Region, 2022-2032(USD Billion)
  12. North America Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  13. North America Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  14. U.S. Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  15. U.S. Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  16. Canada Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  17. Canada Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  18. Mexico Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  19. Mexico Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  20. Europe Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  21. Europe Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  22. Germany Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  23. Germany Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  24. France Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  25. France Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  26. U.K. Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  27. U.K. Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  28. Italy Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  29. Italy Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  30. Spain Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  31. Spain Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  32. Asia Pacific Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  33. Asia Pacific Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  34. Japan Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  35. Japan Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  36. China Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  37. China Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  38. India Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  39. India Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  40. South America Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  41. South America Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  42. Brazil Ischemia Reperfusion Injury Market, By Injury, 2022-2032(USD Billion)
  43. Brazil Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  44. The Middle East and Africa Ischemia Reperfusion Injury Market, Injury, 2022-2032(USD   Billion)
  45. The Middle East and Africa Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)
  46. UAE Ischemia Reperfusion Injury Market, Injury, 2022-2032(USD Billion)
  47. UAE Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion) 
  48. South Africa Ischemia Reperfusion Injury Market, Injury, 2022-2032(USD Billion)
  49. South Africa Ischemia Reperfusion Injury Market, By End Users, 2022-2032(USD Billion)

 

List of Figures 

  1. Global Ischemia Reperfusion Injury Market Segmentation
  2. Ischemia Reperfusion Injury Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Ischemia Reperfusion Injury Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Ischemia Reperfusion Injury Market
  20. Ischemia Reperfusion Injury Market Segmentation, By Injury
  21. Ischemia Reperfusion Injury Market, For Heart Injury, By Region, 2022-2032 ($ Billion)
  22. Ischemia Reperfusion Injury Market, For Kidney Injury, By Region, 2022-2032 ($ Billion)
  23. Ischemia Reperfusion Injury Market, For Intestine Injury, By Region, 2022-2032 ($ Billion)
  24. Ischemia Reperfusion Injury Market, For Others, By Region, 2022-2032 ($ Billion)
  25. Ischemia Reperfusion Injury Market Segmentation, By End Users
  26. Ischemia Reperfusion Injury Market, For Hospital, By Region, 2022-2032 ($ Billion)
  27. Ischemia Reperfusion Injury Market, For Clinic, By Region, 2022-2032 ($ Billion)
  28. Ischemia Reperfusion Injury Market, For Ambulatory Services, By Region, 2022-2032 ($ Billion)
  29. Ischemia Reperfusion Injury Market, For Nursing Home, By Region, 2022-2032 ($ Billion)
  30. Amyndas Pharmaceuticals LLC: Net Sales, 2022-2032 ($ Billion)
  31. Amyndas Pharmaceuticals LLC: Revenue Share, By Segment, 2022 (%)
  32. Amyndas Pharmaceuticals LLC: Revenue Share, By Region, 2022 (%)
  33. ANGION: Net Sales, 2022-2032 ($ Billion)
  34. ANGION: Revenue Share, By Segment, 2022 (%)
  35. ANGION: Revenue Share, By Region, 2022 (%)
  36. Bolder Biotechnology: Net Sales, 2022-2032 ($ Billion)
  37. Bolder Biotechnology: Revenue Share, By Segment, 2022 (%)
  38. Bolder Biotechnology: Revenue Share, By Region, 2022 (%)
  39. Opsona Therapeutics Ltd.: Net Sales, 2022-2032 ($ Billion)
  40. Opsona Therapeutics Ltd.: Revenue Share, By Segment, 2022 (%)
  41. Opsona Therapeutics Ltd.: Revenue Share, By Region, 2022 (%)
  42. Pharming Group NV: Net Sales, 2022-2032 ($ Billion)
  43. Pharming Group NV: Revenue Share, By Segment, 2022 (%)
  44. Pharming Group NV: Revenue Share, By Region, 2022 (%)
  45. Prolong Pharmaceuticals: Net Sales, 2022-2032 ($ Billion)
  46. Prolong Pharmaceuticals: Revenue Share, By Segment, 2022 (%)
  47. Prolong Pharmaceuticals: Revenue Share, By Region, 2022 (%)
  48. Prothix BV: Net Sales, 2022-2032 ($ Billion)
  49. Prothix BV: Revenue Share, By Segment, 2022 (%)
  50. Prothix BV: Revenue Share, By Region, 2022 (%)
  51. Stealth BioTherapeutics, Inc.: Net Sales, 2022-2032 ($ Billion)
  52. Stealth BioTherapeutics, Inc.: Revenue Share, By Segment, 2022 (%)
  53. Stealth BioTherapeutics, Inc.: Revenue Share, By Region, 2022 (%)
  54. Zealand Pharma A/S: Net Sales, 2022-2032 ($ Billion)
  55. Zealand Pharma A/S: Revenue Share, By Segment, 2022 (%)
  56. Zealand Pharma A/S: Revenue Share, By Region, 2022 (%)
  57. Faraday Pharmaceuticals Inc.: Net Sales, 2022-2032 ($ Billion)
  58. Faraday Pharmaceuticals Inc.: Revenue Share, By Segment, 2022 (%)
  59. Faraday Pharmaceuticals Inc.: Revenue Share, By Region, 2022 (%)
  60. SBI Pharmaceuticals: Net Sales, 2022-2032 ($ Billion)
  61. SBI Pharmaceuticals: Revenue Share, By Segment, 2022 (%)
  62. SBI Pharmaceuticals: Revenue Share, By Region, 2022 (%)
  63. Omeros Corporations.: Net Sales, 2022-2032 ($ Billion)
  64. Omeros Corporations: Revenue Share, By Segment, 2022 (%)
  65. Omeros Corporations: Revenue Share, By Region, 2022 (%)
  66. Orexo AB: Net Sales, 2022-2032 ($ Billion)
  67. Orexo AB: Revenue Share, By Segment, 2022 (%)
  68. Orexo AB: Revenue Share, By Region, 2022 (%)
  69. Pledpharma AB: Net Sales, 2022-2032 ($ Billion)
  70. Pledpharma AB: Revenue Share, By Segment, 2022 (%)
  71. Pledpharma AB: Revenue Share, By Region, 2022 (%)
  72. Proteo: Net Sales, 2022-2032 ($ Billion)
  73. Proteo: Revenue Share, By Segment, 2022 (%)
  74. Proteo: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:123
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:3.7%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies